Total intracranial hemorrhage volume measurement summating all compartments best in traumatic and nontraumatic intracranial bleeding
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, randomizované kontrolované studie
PubMed
38680018
PubMed Central
PMC11056697
DOI
10.1002/brb3.3481
Knihovny.cz E-zdroje
- Klíčová slova
- neuroimaging, neurology, neuroscience, stroke,
- MeSH
- dospělí MeSH
- faktor Xa * MeSH
- inhibitory faktoru Xa aplikace a dávkování terapeutické užití MeSH
- intrakraniální krvácení * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mozek diagnostické zobrazování MeSH
- rekombinantní proteiny aplikace a dávkování MeSH
- reprodukovatelnost výsledků MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
- Názvy látek
- faktor Xa * MeSH
- inhibitory faktoru Xa MeSH
- PRT064445 MeSH Prohlížeč
- rekombinantní proteiny MeSH
BACKGROUND AND PURPOSE: The ANNEXA-4 trial measured hemostatic efficacy of andexanet alfa in patients with major bleeding taking factor Xa inhibitors. A proportion of this was traumatic and nontraumatic intracranial bleeding. Different measurements were applied in the trial including volumetrics to assess for intracranial bleeding depending on the compartment involved. We aimed to determine the most reliable way to measure intracranial hemorrhage (ICrH) volume by comparing individual brain compartment and total ICrH volume. METHODS: Thirty patients were randomly selected from the ANNEXA-4 database to assess measurement of ICrH volume by compartment and in total. Total and compartmental hemorrhage volumes were measured by five readers using Quantomo software. Each reader measured baseline hemorrhage volumes twice separated by 1 week. Twenty-eight different ANNEXA-4 subjects were also randomly selected to assess intra-rater reliability of total ICrH volume measurement change at baseline and 12-h follow up, performed by three readers twice to assess hemostatic efficacy categories used in ANNEXA-4. RESULTS: Compartmental minimal detectable change percentages (MDC%) ranged between 9.72 and 224.13, with the greatest measurement error occurring in patients with a subdural hemorrhage. Total ICrH volume measurements had the lowest MDC%, which ranged between 6.57 and 33.52 depending on the reader. CONCLUSION: Measurement of total ICrH volumes is more accurate than volume by compartment with less measurement error. Determination of hemostatic efficacy was consistent across readers, and within the same reader, as well as when compared to consensus read. Volumetric analysis of intracranial hemostatic efficacy is feasible and reliable when using total ICrH volumes.
Biopharmaceuticals R and D AstraZeneca Mölndal Sweden
Department of Clinical Neurosciences University of Calgary Calgary Canada
Department of Medicine Division of Neurology Royal Columbian Hospital New Westminster Canada
Department of Medicine Division of Neurology University of Alberta Edmonton Canada
Department of Medicine McMaster University Hamilton Ontario Canada
Department of Neurology Kyoto Prefectural University of Medicine Kyoto Japan
Department of Neurology University Hospital Ostrava Ostrava Czech Republic
Department of Radiology Seoul Medical Center Seoul South Korea
Department of Radiology University of Calgary Calgary Canada
Faculty of Medicine Masaryk University Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Unit of Neurology San Jacopo Hospital Pistoia Italy
University Hospital Carl Gustav Carus Dresden Dresden Germany
Zobrazit více v PubMed
Brouwers, H. B. , Chang, Y. , Falcone, G. J. , Cai, X. , Ayres, A. M. , Battey, T. W. K. , Vashkevich, A. , Mcnamara, K. A. , Valant, V. , Schwab, K. , Orzell, S. C. , Bresette, L. M. , Feske, S. K. , Rost, N. S. , Romero, J. M. , Viswanathan, A. , Chou, S. H.‐Y. , Greenberg, S. M. , Rosand, J. , & Goldstein, J. N. (2014). Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurology, 71, 158–164. PubMed PMC
Christensen, M. C. , Mayer, S. , & Ferran, J.‐M. (2009). Quality of life after intracerebral hemorrhage: Results of the factor seven for acute hemorrhagic stroke (fast) trial. Stroke; A Journal of Cerebral Circulation, 40, 1677–1682. PubMed
Connolly, S. J. , Milling, T. J. , Eikelboom, J. W. , Gibson, C. M. , Curnutte, J. T. , Gold, A. , Bronson, M. D. , Lu, G. , Conley, P. B. , Verhamme, P. , Schmidt, J. , Middeldorp, S. , Cohen, A. T. , Beyer‐Westendorf, J. , Albaladejo, P. , Lopez‐Sendon, J. , Goodman, S. , Leeds, J. , Wiens, B. L. , … Crowther, M. (2016). Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. New England Journal of Medicine, 375, 1131–1141. PubMed PMC
Davis, S. M. , Broderick, J. , Hennerici, M. , Brun, N. C. , Diringer, M. N. , Mayer, S. A. , Begtrup, K. , & Steiner, T. (2006). Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology, 66, 1175–1181. PubMed
Demchuk, A. M. , Dowlatshahi, D. , Rodriguez‐Luna, D. , Molina, C. A. , Blas, Y. S. , Dzialowski, I. , Kobayashi, A. , Boulanger, J.‐M. , Lum, C. , Gubitz, G. , Padma, V. , Roy, J. , Kase, C. S. , Kosior, J. , Bhatia, R. , Tymchuk, S. , Subramaniam, S. , Gladstone, D. J. , Hill, M. D. , & Aviv, R. I. (2012). Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT‐angiography spot sign (predict): A prospective observational study. Lancet Neurology, 11, 307–314. PubMed
Dontje, M. L. , Dall, P. M. , Skelton, D. A. , Gill, J. M. R. , & Chastin, S. F. M. (2018). Reliability, minimal detectable change and responsiveness to change: Indicators to select the best method to measure sedentary behaviour in older adults in different study designs. PLoS ONE, 13, e0195424. PubMed PMC
Fogelholm, R. (2005). Long term survival after primary intracerebral haemorrhage: A retrospective population based study. Journal of Neurology, Neurosurgery, and Psychiatry, 76, 1534–1538. PubMed PMC
Gavrielides, M. A. , Li, Q. , Zeng, R. , Myers, K. J. , Sahiner, B. , & Petrick, N. (2013). Minimum detectable change in lung nodule volume in a phantom CT study. Academic Radiology, 20, 1364–1370. PubMed
Hemphill, J. C. , Bonovich, D. C. , Besmertis, L. , Manley, G. T. , & Johnston, S. C. (2001). The ICH score: A simple, reliable grading scale for intracerebral hemorrhage. Stroke; A Journal of Cerebral Circulation, 32, 891–897. PubMed
Katajapuu, N. , Heinonen, A. , & Saltychev, M. (2020). Minimal clinically important difference and minimal detectable change of the world health organization disability assessment schedule 2.0 (whodas 2.0) amongst patients with chronic musculoskeletal pain. Clinical Rehabilitation, 34, 1506–1511. PubMed PMC
Kosior, J. C. , Idris, S. , Dowlatshahi, D. , Alzawahmah, M. , Eesa, M. , Sharma, P. , Tymchuk, S. , Hill, M. D. , Aviv, R. I. , Frayne, R. , Demchuk, A. M. , & PREDICT/Sunnybrook CTA ICH Study Investigators . (2011). Quantomo: Validation of a computer‐assisted methodology for the volumetric analysis of intracerebral haemorrhage. International Journal of Stroke, 6, 302–305. PubMed
Oda, S. , Awai, K. , Murao, K. , Ozawa, A. , Yanaga, Y. , Kawanaka, K. , & Yamashita, Y. (2010). Computer‐aided volumetry of pulmonary nodules exhibiting ground‐glass opacity at MDCT. AJR, American Journal of Roentgenology, 194, 398–406. PubMed
Oxnard, G. R. , Zhao, B. , Sima, C. S. , Ginsberg, M. S. , James, L. P. , Lefkowitz, R. A. , Guo, P. , Kris, M. G. , Schwartz, L. H. , & Riely, G. J. (2011). Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes. Journal of Clinical Oncology, 29, 3114–3119. PubMed PMC
Piedrahita‐Alonso, E. , Valverde‐Megias, A. , Martin‐Garcia, B. , Hernandez‐Garcia, E. , & Gomez‐de‐Liano, R. (2021). Minimal detectable change of the disc‐fovea angle for ocular torsion assessment. Ophthalmic & Physiological Optics, 42(1), 133–139. PubMed
Rodriguez‐Luna, D. , Boyko, M. , Subramaniam, S. , Klourfeld, E. , Jo, P. , Diederichs, B. J. , Kosior, J. C. , Dowlatshahi, D. , Aviv, R. I. , Molina, C. A. , Hill, M. D. , & Demchuk, A. M. (2016). Magnitude of hematoma volume measurement error in intracerebral hemorrhage. Stroke; A Journal of Cerebral Circulation, 47, 1124–1126. PubMed
Rost, N. S. , Smith, E. E. , Chang, Y. , Snider, R. W. , Chanderraj, R. , Schwab, K. , Fitzmaurice, E. , Wendell, L. , Goldstein, J. N. , Greenberg, S. M. , & Rosand, J. (2008). Prediction of functional outcome in patients with primary intracerebral hemorrhage: The FUNC score. Stroke; A Journal of Cerebral Circulation, 39, 2304–2309. PubMed
Sacco, S. , Marini, C. , Toni, D. , Olivieri, L. , & Carolei, A. (2009). Incidence and 10‐year survival of intracerebral hemorrhage in a population‐based registry. Stroke; A Journal of Cerebral Circulation, 40, 394–399. PubMed
Zahuranec, D. B. , Lisabeth, L. D. , Sánchez, B. N. , Smith, M. A. , Brown, D. L. , Garcia, N. M. , Skolarus, L. E. , Meurer, W. J. , Burke, J. F. , Adelman, E. E. , & Morgenstern, L. B. (2014). Intracerebral hemorrhage mortality is not changing despite declining incidence. Neurology, 82, 2180–2186. PubMed PMC